View Information Collection Request (ICR) Package

OMB Control No: 0920-1091	ICR Reference No: 202010-0920-010
Status: Historical Active	Previous ICR Reference No: 201808-0920-012
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-1091
Title: Using Qualitative Methods to Understand Issues in HIV Prevention, Care and Treatment in the United States CHANGE REQUEST to Mitigate COVID-19 Risks: Using Qualitative Methods [...]
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 11/18/2020
	Date Received in OIRA: 11/12/2020
Terms of Clearance: Previous terms continue: OMB approves this collection for a period of three years. To request approval of information collections under this generic approval, the agency must do the following: 1) Submit a Supporting Statement Part A and B for each generic sub-study; 2) Submit the instruments utilized for each generic collection; 3) Include documentation demonstrating IRB approval/exemption; 4) Include specific discussions on the non-generalizable nature of the data collected in all publications and presentations.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	09/30/2021	09/30/2021	09/30/2021
Responses	12,000	0	12,000
Time Burden (Hours)	2,754	0	2,754
Cost Burden (Dollars)	0	0	0

Abstract: This is an EXTENSION request for the current GENERIC information collection request (ICR) 0920-1091. The overall purpose of this GENERIC ICR is to conduct qualitative studies to quickly identify barriers and facilitators to HIV prevention, care and treatment in specific regions with high HIV burden in the US. Intended use of the resulting data is to identify ways to improve local programmatic activities for specific communities along the continuum of HIV prevention, treatment and care for populations and areas with the greatest HIV burden. These qualitative studies will collect data using well-established rapid assessment methodologies, including: semi-structured and in-depth qualitative interviews, focus groups; direct observations; document reviews; and structured surveys. The populations to be studied include local networks of persons living with HIV and persons at high risk of acquiring HIV, including: persons with different racial and ethnic, age, and socioeconomic characteristics; men who have sex with men; transgender persons; women; and persons and organizations providing HIV prevention, care, and treatment services to impacted populations. Data will be analyzed using well-established qualitative analysis methods, such as coding interviews for themes about barriers and successes to HIV prevention, care, and treatment. Structured response surveys will be analyzed using descriptive statistics and other appropriate statistical methods. Some project methods have been modified to mitigate the risks of transmitting COVID-19.

Authorizing Statute(s): US Code: 42 USC 241 Name of Law: Public Health Service Act

Citations for New Statutory Requirements: None

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	83 FR 10853	03/13/2018
30-day Notice:	Federal Register Citation:	Citation Date:
	83 FR 34589	07/20/2018
Did the Agency receive public comments on this ICR? Yes

ICR Summary of Burden

	Total Approved	Previously Approved
Annual Number of Responses	12,000	12,000
Annual Time Burden (Hours)	2,754	2,754
Annual Cost Burden (Dollars)	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

Annual Cost to Federal Government: $517,658

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Yes

Agency Contact: Renita Macaluso 770 488-6458 arp5@cdc.gov

View Generic ICR - OIRA Conclusion